1. Home
  2. NBIX vs OVV Comparison

NBIX vs OVV Comparison

Compare NBIX & OVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$167.43

Market Cap

17.7B

Sector

Health Care

ML Signal

N/A

Logo Ovintiv Inc. (DE)

OVV

Ovintiv Inc. (DE)

N/A

Current Price

$65.32

Market Cap

20.0B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
NBIX
OVV
Founded
1992
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
17.7B
20.0B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
NBIX
OVV
Price
$167.43
$65.32
Analyst Decision
Strong Buy
Buy
Analyst Count
28
25
Target Price
★ $208.11
$82.05
AVG Volume (30 Days)
1.3M
★ 3.3M
Earning Date
11-02-2026
11-03-2026
Dividend Yield
N/A
★ 1.85%
EPS Growth
★ 41.95
13.54
EPS
★ 5.26
1.36
Revenue
$161,626,000.00
★ $8,908,000,000.00
Revenue This Year
$39.52
$17.07
Revenue Next Year
$14.81
N/A
P/E Ratio
★ $32.28
$47.68
Revenue Growth
★ 977.51
N/A
52 Week Low
$122.14
$36.81
52 Week High
$186.12
$73.62

Technical Indicators

Market Signals
Indicator
NBIX
OVV
Relative Strength Index (RSI) 66.05 49.88
Support Level $152.67 $56.66
Resistance Level $169.57 $67.45
Average True Range (ATR) 5.47 2.25
MACD 2.07 -0.57
Stochastic Oscillator 80.70 44.83

Price Performance

Historical Comparison
NBIX
OVV

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About OVV Ovintiv Inc. (DE)

Ovintiv is an independent oil and gas producer focused on Canada's Montney and the US' Permian basins. Historically, it has been an acquisitive producer across numerous basins and plays but has divested and exited all but two. It remains an active buyer in the remaining footprint. The firm estimates that it has up to 20 and 15 years of inventory remaining in the Montney and Permian basins, respectively.

Share on Social Networks: